Dianthus Therapeutics, Inc. DNTH
82.25 USD -0.13 -0.16%
At close · Nov 2
81.50 -0.75 -0.91%
After hours · Nov 2, 4:00 PM ET
32.28 52-week range 117.88
- YTD
- +99.59%
- 1 year
- +135.13%
- Open
- 82.46
- Prev close
- 82.38
- Mkt cap
- 4.60B
- Vol
- 837.80K
- Avg vol
- 813.33K
- EPS
- -4.24
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 80.75
- High
- 84.56
- Forward P/E
- -17.84
- Beta
- 0.26
- Short ratio
- 9.16
- Inst. own
- 129.89%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 92.76
- 200-d avg
- 85.03
- 1y target
- 139.06
5m chart
Chart tools
Chart is warming up
The five-minute interval price history for DNTH has not been loaded yet. Try again in a moment.
Altman Z-Score
67.20 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 5
- P/E 1
- P/B 2
P/E -9.8×
P/S 765×
P/B 3.2×
P/FCF -12.0×
EV/EBITDA -9.3×
EV/Sales 741×
FCF Yield -8.3%
Gross Margin 100.0%
Operating Margin -8739.3%
Net Margin -7973.3%
ROE -32.9%
ROIC -35.5%
ROA -30.6%
Revenue -67.3%
Operating Income -74.7%
EPS (diluted) -64.7%
Free Cash Flow -65.1%
Current Ratio 13.3×
Quick Ratio 13.3×
Debt / Equity 0.0×
Net Debt / EBITDA 0.3×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31